KATIE NADING: Open Payments
NPI 1053912196 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,795 in 343 payments from 42 companies in 2025. Trend: 2023 $4,374 · 2024 $6,988 · 2025 $9,795
Food & beverage: $8,733Travel & lodging: $1,062
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 77 | $1,600 |
| LivaNova USA, Inc. | 4 | $1,302 |
| PFIZER INC. | 40 | $596 |
| TG Therapeutics, Inc. | 14 | $547 |
| Eisai Inc. | 8 | $428 |
| Novartis Pharmaceuticals Corporation | 17 | $367 |
| Lundbeck LLC | 13 | $354 |
| ACADIA Pharmaceuticals Inc | 12 | $319 |
| Neurocrine BioSciences, Inc. | 18 | $305 |
| Lilly USA, LLC | 16 | $304 |
Products named: VNS Therapy, QULIPTA, BRIUMVI, BOTOX, KESIMPTA, VYEPTI, NURTEC ODT, INGREZZA.
Industry payments across CO — which companies pay providers there.
